Navigation Links
Royalty Pharma Acquires a Portion of Northwestern University's Royalty Interest in Lyrica(R) for $700 Million
Date:12/18/2007

al law to help support financial aid for undergraduate and graduate students; startup costs for the University's research efforts; construction of new buildings and laboratories and improvements to existing facilities; and for other purposes.

"Essentially, we are converting a potential stream of future royalty revenues from Lyrica into an immediate cash payment," Sunshine explained. "We continue to believe strongly in Lyrica's potential and Northwestern retains a large portion of those royalty rights, but by doing this, we are diversifying the University's investments."

The percentage of the University's interest in the royalty payments that was sold today is not being disclosed.

Morgan Stanley is acting as structuring advisor and Covington & Burling LLP is acting as the legal advisor to Northwestern University for this sale. Goodwin Procter LLP is acting as legal advisor to Royalty Pharma for this sale.

About Northwestern University

Founded in 1851, Northwestern University is a leading private research and teaching university with an enrollment of approximately 8,000 full-time undergraduate students and approximately 7,000 full-time graduate and professional students on campuses in Evanston and Chicago, Illinois.

Northwestern combines innovative teaching and pioneering research in a highly collaborative environment that transcends traditional academic boundaries. Northwestern provides students and faculty exceptional opportunities for intellectual, personal and professional growth in a setting enhanced by the richness of Chicago.

For more information, go to: http://www.northwestern.edu

About Royalty Pharma

Royalty Pharma is the industry leader in acquiring revenue-producing intellectual property -- principally royalty interests in marketed and late stage biopharmaceutical products with a market value of over $4.5 billion. Royalty Pharma currently o
'/>"/>

SOURCE Royalty Pharma
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Unilens Vision Reports Record First Quarter Earnings and Royalty Income
2. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
3. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
9. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
10. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...te Shows Who Sides With Working Families vs. Insur...ewswire-USNewswire/ -- On the heels of an historic...or a good, balanced health care reform bill, the P...r state,s U.S. representatives voted on HR 3962, t...The legislation, which passed Saturday evening by ...
(Date:11/7/2009)..., The American Medical ...Rush Award for Citizenship and Community Service t...icago, IL. The award recognizes physicians who hav... duty to make an outstanding public service contri...d the award today during the opening session of th...
(Date:11/7/2009).... 7 With the final Hous...tremists are holding the entire bill hostage to fu...g that the bill go far beyond the status quo restr...o the original bill. In an outrageous amendment, ...ternoon, antichoice Democrats are demanding explic...
(Date:11/7/2009)...e Public Relations Society of America (PRSA) will ...Gage Lofgren, senior vice president of Brand Strat...tonight at a ceremony at PRSA,s 2009 International...o the PRSA College of Fellows is one of the profes...rman, APR, SAGE, Fellow PRSA, and 2009 chair of th...
(Date:11/7/2009)... Forget ‘sweatox’ or ‘Boytox&...age of the anti-ageing jab ‘Breastox’ ... the décolletage, can reduce the appearance...round the breasts, leaving smoother, younger-looki...er 7, 2009 -- Transform, the UK’s largest gr...
Breaking Medicine News(10 mins):Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3Health News:UK Boobs Get a Boost with 'Breastox' 2
... after revelation that Peanut Corp. of America shi...break, FDA announces , , FRIDAY, Jan. 30 (...criminal investigation into the salmonella outbrea...e criminal violations at the Georgia processing pl...
...an. 30 Americans resolving to eat healthier and m...e also likely to look for ways to trim their groce...reasing nutritional intake? Dr. Praeger,s Sensible...hier lifestyle choices during tough economic times...
...S. Vincent Grasso, a member of the Stevens Healthc...rd was selected to lead the technical team on a $5...AA compliant, web-based data entry and reporting p...or HIV Women of Color. The grant proposal brings t...
...matic brain injury (TBI) has been identified as th...nistan. , TBI is known to cause deficits in mem...s in conjunction with post-traumatic stress disord...gathered by the Veterans Administration,s (VA) Qua...
...rnors Association Center meeting highlights IBC,s ...nitiative in southeastern PA , , PHILADELPHIA, Ja...nt of Health Services Richard Snyder, MD, yesterda...nter meeting for Best Practices in New Orleans. La...
.... 30 Stryker Corporation (NYSE: SYK ) announced...Wednesday, May 20, 2009, at 8:00 a.m. Eastern Time..., President and Chief Executive Officer, will host...r,s website at www.stryker.com via the For Inves...
Other Medicine News:Health News:U.S. Launches Criminal Probe Into Salmonella Outbreak 2Health News:U.S. Launches Criminal Probe Into Salmonella Outbreak 3Health News:Lower Your Grocery Bill, Improve Health In 2009: Top Tips From Dr. Praeger's Sensible Foods 2Health News:Lower Your Grocery Bill, Improve Health In 2009: Top Tips From Dr. Praeger's Sensible Foods 3Health News:Grasso leads technical team's response to HHS HIV/AIDS Bureau announcement 2Health News:Grasso leads technical team's response to HHS HIV/AIDS Bureau announcement 3Health News:Study of Iraq veterans' traumatic brain injuries to be conducted by UB researchers 2Health News:Patient-Centered Medical Homes Can Improve Care, Reduce Costs; Independence Blue Cross Medical Executive Discusses Innovative PA Program With Nation's Health Care Policy Makers 2Health News:Patient-Centered Medical Homes Can Improve Care, Reduce Costs; Independence Blue Cross Medical Executive Discusses Innovative PA Program With Nation's Health Care Policy Makers 3Health News:Stryker to Host Analyst Meeting 2
(Date:11/6/2009)... PARIS, November 6 , - ...Linezolid for the,Treatment of Multi-Resistant Sta...vexel, a speciality pharmaceutical company focused...tics designed to overcome the significant global,p...at its most advanced oral,antibacterial NXL103 (fl...
(Date:11/5/2009)...OINT RICHMOND, Calif., Nov. 5 /PRNewswire-FirstCal...PT ), a specialty pharmaceutical company focused o...tary products that address important therapeutic n... it will host a webcast and teleconference with ma...esults on Thursday, November 12, 2009, at 5:00 p.m...
(Date:11/5/2009)...ULLERTON, Calif., Nov. 5 Renee Cob...ate professor of dermatology at the University of ...nts are experiencing tremendous results with Therm...ed for skin tightening and contouring, features a ...efficacy and improves patient comfort. ,, "The...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2What are the most effective ways of promoting physical exercise in adults 3F 51564 1What are the most effective ways of promoting physical exercise in adults 3F 51564 2What are the most effective ways of promoting physical exercise in adults 3F 51564 3Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 1Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 2Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 3Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 4Pelosi Statement on Appointment of Dr Regina Benjamin as Surgeon General of the United States 51560 1
...or Cancer Research meeting indicate that technolo...-water-soluble drugs to treat cancer and possibly ...r Pharmaceuticals today,reported results on a nove...pable of dissolving in water (hydrophobic drugs) i...ation. These findings allow the company to,combine...
...MOND, Va., April 16 Insmed Inc. (Nasdaq:,INSM), a...ticals, today,announced that it has received appro...care products Regulatory Agency (MHRA) to initiate...n biologic (FOB) product candidate.,Insmed,s INS-1...a follow-on,biologic of the FDA-approved product N...
Other Medicine Technology:Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 2Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 2Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 4
...e any trocar system you've ever seen., ,The OnePo...n one designed to be versatile, operationally fle...., ,By offering options in disposability and blad...ctively address the individual preferences of the ...
Reusable Thoracoscopy Cannula
...separate components: an exchange rod, a dilating o...ent trocar sleeve. The exchange rod is a rigid cyl... dilating obturator is tapered and threaded at the...the 10/11mm or the 12mm ENDOPATH surgical trocar. ...
...trocar should be a seamless part of any procedure,...e process. So we spent over three years designing ...g surgeons., ,Introducing the ENDOPATH® Xcel&...unencumbered, hassle-free, laparoscopic access., ...
Medicine Products: